Accordingly, in mice exposed to a HFD for 6 weeks, treatment with the CB2 agonist JWH-133 enhanced insulin resistance, as assessed by the insulin tolerance test (p<0.05 by two way ANOVA) (Fig 5 D). Here, INS is linked to Insulin resistance.